Jin Chen, MD, PhD, is a Professor of Medicine in the Division of Rheumatology and Immunology, Department of Medicine, at Vanderbilt University Medical Center. She received her MD from Shanghai First Medical College and PhD in Biochemistry and Molecular Pharmacology from Harvard University. She pursued postdoctoral research at MIT and Vanderbilt University. In 1997, she became an Assistant Professor at Vanderbilt University, working on dissecting the role Eph receptor tyrosine kinases in cancer and tumor microenvironment. Her laboratory performed pioneering studies on determining EphA receptor function in tumor initiation, metastatic progression and tumor angiogenesis. More recently, her laboratory focuses on investigating how metabolic changes in tumor microenvironment affect antitumor immunity. Dr. Chen's scientific discoveries are recognized nationally and internationally. She is has been continuously funded by National Cancer Institute (NCI) for the last 25 years and publishes in high impact journals such as Journal of Clinical Investigation and Cancer Research. She is also a sought-after speaker at academic institutions, national symposiums/meetings, and European Molecular Biology (EMBO) conferences. She has been serving on multiple NIH study sections as a member, co-chair, or acting chair, as well as a member of NCI intramural research program site visit panel. In addition, she has been awarded a Senior Research Career Scientist at VA TVHS Medical Center and Ingram Professor of Cancer Research. Aside from scientific research, Dr. Chen devoted much of her time in education and training. She is director of graduate studies in cancer biology and the director of an NCI T-32 training program. Nationally, she has been actively participating in the Cancer Biology Training Consortium (CABTRAC), and has served on its board of directors from 2011-2014, and again in 2018-2021.
MD - Shanghai Medical University, 1984
PhD - Harvard University, 1991
777 Preston Research Building
2220 Pierce Ave
Nashville, TN 37232-6307